Level Four Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Buy |
1,209
+167
| +16% | +$67.7K | 0.02% | 528 |
|
|
2025
Q1 | $519K | Sell |
1,042
-76
| -7% | -$37.8K | 0.02% | 493 |
|
|
2024
Q4 | $582K | Buy |
1,118
+139
| +14% | +$72.3K | 0.02% | 462 |
|
|
2024
Q3 | $535K | Buy |
979
+61
| +7% | +$33.3K | 0.02% | 492 |
|
|
2024
Q2 | $508K | Sell |
918
-418
| -31% | -$231K | 0.02% | 482 |
|
|
2024
Q1 | $709K | Hold |
1,336
| – | – | 0.04% | 369 |
|
|
2023
Q4 | $709K | Sell |
1,336
-81
| -6% | -$43K | 0.04% | 368 |
|
|
2023
Q3 | $717K | Sell |
1,417
-50
| -3% | -$25.3K | 0.05% | 353 |
|
|
2023
Q2 | $765K | Buy |
1,467
+100
| +7% | +$52.2K | 0.05% | 351 |
|
|
2023
Q1 | $788K | Buy |
1,367
+14
| +1% | +$8.07K | 0.05% | 327 |
|
|
2022
Q4 | $745K | Buy |
1,353
+663
| +96% | +$365K | 0.06% | 310 |
|
|
2022
Q3 | $350K | Sell |
690
-49
| -7% | -$24.9K | 0.03% | 390 |
|
|
2022
Q2 | $402K | Sell |
739
-4
| -0.5% | -$2.18K | 0.04% | 379 |
|
|
2022
Q1 | $439K | Sell |
743
-6
| -0.8% | -$3.55K | 0.03% | 427 |
|
|
2021
Q4 | $500K | Buy |
749
+355
| +90% | +$237K | 0.04% | 383 |
|
|
2021
Q3 | $225K | Sell |
394
-235
| -37% | -$134K | 0.02% | 428 |
|
|
2021
Q2 | $317K | Sell |
629
-179
| -22% | -$90.2K | 0.02% | 518 |
|
|
2021
Q1 | $369K | Buy |
808
+37
| +5% | +$16.9K | 0.03% | 456 |
|
|
2020
Q4 | $359K | Buy |
771
+71
| +10% | +$33.1K | 0.03% | 428 |
|
|
2020
Q3 | $309K | Sell |
700
-507
| -42% | -$224K | 0.02% | 432 |
|
|
2020
Q2 | $434K | Buy |
1,207
+44
| +4% | +$15.8K | 0.03% | 387 |
|
|
2020
Q1 | $334K | Buy |
1,163
+84
| +8% | +$24.1K | 0.04% | 367 |
|
|
2019
Q4 | $348K | Buy |
+1,079
| New | +$348K | 0.01% | 441 |
|